<DOC>
	<DOCNO>NCT03085134</DOCNO>
	<brief_summary>The primary objective study show infant cow milk protein allergy ( CMPA ) feed new FSMP infant formula reduce level protein &amp; 2 Human Milk Oligosaccharides ( HMOs ) ( test formula ) growth line infant feed comparable FSMP formula without HMOs ( control formula ) . The secondary objective ass whether consumption Test formula CMPA infant ( ) reduce medication use risk infection particular low respiratory tract infections/morbidity , ( ii ) well tolerate allow age appropriate growth ( iii ) reduce health care cost .</brief_summary>
	<brief_title>Clinical Safety &amp; Efficacy New Infant Formula With Specific Medical Purpose Containing Human Milk Oligosaccharides</brief_title>
	<detailed_description>Infants physician diagnose CMPA , age birth 6 month age take either control new test infant formula 4 month judge suitable physician , maximum 12 month age . Growth , adverse event , medication use tolerance formula assess . As part exploratory objective , study also explore possible mode action Test formula CMPA infant , assess whether consumption Test formula CMPA infant affect stool microbiota metabolic signature well urine metabolic signatures whether change associate intestinal inflammatory/health status , clinical measure .</detailed_description>
	<criteria>1 . Full term infant ( 37 week ≤ gestation ≤ 42 week ) 2 . 2500g ≤ birth weight ≤ 4500g 3 . Written informed consent . 4 . Infant age birth 6 month . 5 . Exclusively formulafed time enrollment mother CMPA infant breastfeed independently elect enrollment exclusively formula feed . 6 . Infants physician diagnose ( untreated extensively hydrolyse amino acid infant formula ) Cow Milk Protein Allergy per standard clinical practice least 2 protocol specify symptoms present . 1 . Congenital illness malformation may affect growth . 2 . Demonstrated chronic malabsorption due CMPA . 3 . Significant prenatal and/or serious postnatal disease CMPA enrollment ( per investigator 's medical decision ) . 4 . Minor parent ( ) . 5 . Infants whose parent caregiver expect comply study procedure . 6 . Currently participate participate another clinical trial since birth .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>